semaglutide and diabetes Peptide of the Week: Peptide: A Promising Advancement in Treatment If semaglutide is a diabetes

DATA AVAILABILITY STATEMENT The data sets analysed during the current study are available from the corresponding author upon reasonable request

The retrospective cohort study examined the association between the GLP-1R agonist and the development of NAION over a six-year period in the neuro-ophthalmology clinic

Parker HE, Adriaenssens A, Rogers G, Richards P, Koepsell H, Reimann F, and Gribble FM

Another recent study points out that genetics can influence as much as 50% of a persons propensity to gain weight and difficulty losing it, with the other 50% coming from environmental factors like diet and exercise.2 So, it makes sense that the medical establishment is finally embracing weight loss drugs as more than just a cosmetic concern